Ebola hemorrhagic fever (EHF) patients treated at Kikwit General Hospital during the 1995 outbreak were tested for viral antigen, IgG and IgM antibody, and infectious virus. Viral antigen could be detected in virtually all patients during the acute phase of illness, while antibody was not always detectable before death. Virus was also isolated from patients during the course of their febrile illness, but attempts to quantify virus in Vero E6 cells by standard plaque assay were often unsuccessful. IgG and IgM antibody appeared at approximately the same time after disease onset (8 -10 days), but IgM persisted for a much shorter period among the surviving convalescent patients. IgG antibody was detectable in surviving patients through about 2 years after onset, the latest time that samples were obtained. Detection of Ebola virus antigens or virus isolation appears to be the most reliable means of diagnosis for patients with suspected acute EHF, since patients with this often-fatal disease (80% mortality) may not develop detectable antibodies before death.
Most outbreaks of Ebola (EBO) hemorrhagic fever (EHF)
who already represented a major proportion of the EHF patients [4] . Nevertheless, it was possible to collect and preserve a have occurred in remote areas, and the delayed recognition of the outbreaks has often meant that virus transmission has moderate number of clinical specimens for later analyses at the Centers for Disease Control and Prevention (CDC) and the ceased before scientists could reach the area and safely collect, store, and systematically investigate clinical materials from National Institute for Virology (NIV).
The results of the subsequent laboratory investigations are the patients. Indeed, the medical facilities involved in EHF outbreaks have often been incriminated in the spread of virus presented here. Tests included antigen-detection, IgM-capture, and IgG ELISAs and virus quantitation. Reverse transcriptasefrom patient to patient and even among medical staff. Several EHF patients have been cared for after transport to larger medipolymerase chain reaction (RT-PCR) and nucleotide sequencing were used to establish the initial diagnosis and to identify cal facilities or investigated following the occurrence of laboratory infection [1 -3] . However, these instances are uncommon, the virus as being nearly identical to the prototype virus from the 1976 epidemic in DRC [5] (see Sanchez et al., this issue and only a small number of EHF patients have been tested for virus, virus antigen, and antibody response. [6] ). We also show the evolution of the viral parameters mentioned above and assess the diagnostic utility of these assays The 1995 epidemic in Kikwit, Democratic Republic of the Congo (DRC), appeared to offer unique opportunities for conin various scenarios in which they might be used for laboratory diagnosis of clinically suspected EHF patients. ducting clinical virology studies since the site was relatively accessible and the outbreak was still active when the etiologic diagnosis was established. However, the situation was far from Materials and Methods ideal, and much of the effort initially planned for virologic and immunologic study of patients was necessarily diverted to Collection and handling of clinical specimens. Initial specirestoration of hospital services and the institution of barriermens were collected from 14 patients in Kikwit and sent via the nursing practices. This shift was necessary to prevent further Institute for Tropical Medicine in Belgium to CDC as frozen blood infection of medical personnel and family members of patients, [5] . Following the arrival of the CDC response team on 10 May 1995, acutely ill EHF patients were cared for in a supervised, restricted-access, barrier-nursing environment in a pavilion of Kikwit General Hospital [7] . Blood samples were collected in vacu- Figure 1 . Ebola antigen (Ag) and EBO-Z IgM and IgG antibody findings from first samples from patients with laboratory-confirmed Ebola hemorrhagic fever. Data are limited to first samples that were obtained between 5 days before and 10 days after onset. A, Adjusted optical density (OD; measured at 410 nm) sums for 4 dilutions (1:4 -1:256 for antigen detection, 1:100 -1:6400 for IgG and IgM tests). B, Titers assigned to each serum specimen. Horizontal bars represent cutoff or positive-negative threshold for tests. Each ''petal'' on ''sunflower'' (ᮀ) represents data point; sunflowers without petals represent single data points.
Separated sera and clots were labeled and stored in liquid nitroAntigen-detection ELISA. The antigen-detection test was fundamentally as described previously [9] . Modification from the pubgen until transported on dry ice in International Airline Transport Association-compliant safety shippers to the CDC and NIV, lished procedure included testing of clinical materials at dilutions of 1:4 through 1:256 in a 4-fold dilution series and substitution of where the samples were sorted on dry ice and then stored in either gas-phase liquid nitrogen freezers or mechanical 070ЊC freezers.
the previously published detection antibody with a new rabbit serum that was used as the antigen detector. The rabbit serum was For antigen-detection and serologic tests, the serum samples were taken into a biosafety level 4 (BSL-4) laboratory and thawed, an a polyvalent hyperimmune serum made to the EBO virus subtypes that were known at the time it was made in 1991: EBO Zaire aliquot was placed into a designated well of a microtiter format tube holder (Bio-Rad, Emeryville, CA) and sealed with paraffin (EBO-Z), EBO Sudan, and EBO Reston. The test was performed on materials that had been irradiated as mentioned above. The film, and the holder and contents were double heat-sealed in plastic bags. The sealed samples were passed out through a 3% Lysol results for each sample are presented as both the titer and as the sum of the adjusted (specific capture less mock capture well) opti-(PRO Brands, Wayne, NJ) immersion tank and frozen on dry ice before being irradiated (while chilled with dry ice) with 2 1 10 6 cal density (OD) values from all of the four dilutions. Samples were considered positive if the antigen titer was 1:16 and the sum rads (20,000 Gy) of gamma in a cobalt irradiator (Gammacel 220; Nordion International, Kanata, Canada). Specimens to be used adjusted OD was ú0.45. For calculation of mean titers for the antigen-detection ELISA, a value of 1 was assigned to those specifor virus isolation and enumeration by virus assays (see below) remained in the BSL-4 laboratory and were handled in the same mens that had titers õ1:4, the first dilution tested. manner. The assays were initiated within a BSL-4 laboratory at IgM and IgG ELISAs. The EBO-Z IgM antibody in patient the same time as the samples were thawed to make aliquots for sera was measured with an IgM capture format that is often used serologic tests.
for arboviruses and hemorrhagic fevers. The test follows one that was originally described for hepatitis A virus [10] and as adapted Tests were initially performed as sample batches as they arrived at CDC. To examine temporal patterns, we chose a subset of for EBO virus [11] . A modified antigen was used in the assay. It was prepared in a BSL-4 laboratory from Vero E6 cells grown in patients, each with §4 specimens, for simultaneous testing. Tests of samples not used in the temporal analyses were not repeated roller bottles, infected with the prototype (Mayinga) EBO-Z virus, and harvested when virtually all the cells had become infected. unless warranted by quality-control procedures. The roller bottles with infected cells were frozen and thawed, the prototype strain (Mayinga) of EBO-Z [11]. Mock antigens were prepared in the same manner from uninfected E6 cells. Each serum cells and medium were decanted, and 0.1 M Tris, pH 8.5, was added to buffer the medium. The medium and cells were then sample was tested at the same dilution series as mentioned above for the IgM capture ELISA. An anti-human IgG (gamma chainrefrozen in plastic bottles, heat-sealed in double bags in the BSL-4 laboratory, passed through a 3% lysol immersion tank, and frozen specific) horseradish peroxidase conjugate (Accurate Chemical, Grand Island, NY) and H 2 O 2 -ABTS substrate system were used on dry ice before being irradiated with 5 1 10 6 rads (50,000 Gy) of gamma in a cobalt irradiator. The material was then thawed, to detect bound immunoglobulins. Adjusted OD values, measured at 410 nm, were calculated in the same manner as given above sonicated, and dispensed into small containers for use as the antigen in IgM capture assays. A mock-infected Vero E6 antigen was for the IgM test; however, cutoff values §0.25 greater were required for each dilution to be considered positive, and titer values similarly prepared.
Sera were tested against both the EBO-Z antigen and the mockwere assigned accordingly. Sera with titers §1:400 through the dilution series and adjusted OD sums of §1.25 were considered infected antigens at 4-fold dilutions of 1:100 through 1:6400. The rabbit serum that was used in the antigen-detection test also served IgG positive. For calculation of mean titers for both the IgM and IgG ELISAs, a value of 50 was assigned to those specimens that as the antigen detector in the IgM capture format test. The substrate H 2 O 2 -ABTS (Kirkegaard & Perry, Gaithersburg, MD) was used had titers õ1:100. Virus isolation. Virus isolation was attempted on selected after the anti-rabbit conjugate. The wells were measured on a microplate reader at 410 nm, and the ODs were recorded. The specimens to qualitatively determine if infectious virus was present. Isolation attempts were performed in a BSL-4 laboratory by adjusted OD measured at 410 nm was calculated by subtracting the OD of the mock-infected antigen wells from the corresponding using confluent monolayers of Vero E6 cells in 25-cm 2 plastic tissue culture flasks. Each flask was inoculated with 100 mL of a EBO-Z-infected antigen wells. An adjusted OD of ú0.10 was required for each dilution to be considered positive and for a titer 1/10 dilution of the sample being tested for virus. The flask was then continuously rocked in an incubator (37ЊC) for Ç1 h before to be assigned accordingly. Sera were considered positive if the titer was §1:400 and the sum of the adjusted OD was ú0.6.
7 mL of maintenance medium (Eagle MEM with Earle's salts, 2% heat-inactivated fetal bovine serum, 100 U/mL penicillin, 100 mg/ The IgG ELISA was performed using gamma-inactivated basic buffer detergent extracts of Vero E6 cells infected with the same mL streptomycin, and 50 mg/mL gentamycin) was added. on the flasks were closed tightly, and the flasks were incubated at came contaminated with bacteria or mold were frozen, thawed, passed through a 0.22-mM filter, and reinoculated onto another 37ЊC.
For the first few days, flasks were observed daily for cytopathic flask of confluent Vero E6 cells. At 14 days, or if CPE was obvious and affected ú50% of the cells, the cultures were harvested and effect (CPE), and then they were observed every 2-3 days. The maintenance medium was changed at day 7, and if CPE did not tested for EBO viral antigen by indirect fluorescent antibody test. Cells were detached from the flask by agitation with sterile 3-mm affect ú50% of the cells, cultures were harvested at 14 days and tested for EBO virus antigen as detailed below. Cultures that beglass beads, and Ç4 mL of this cell suspension was labeled and stored at 070ЊC for further use. The remaining Ç3 mL of cell either low or undetectable using this procedure, specimens were tested by this method only at dilutions of 10 01 through 10
03
. All suspension was centrifuged in aerosol guard tube carriers, and the cells were resuspended in Ç0.5 mL of borate saline, pH 9. Using specimens were handled in a laminar flow safety cabinet, and virus control plates were handled at the end of each procedure in a a plastic Pasteur pipette, we placed small drops of the cell suspension onto four wells on each of two Teflon-coated slides (Cellseparate laminar flow safety cabinet in another room in the BSL-4 laboratory. Plates were stained at day 6 by the addition of a Line Associates, Newfield, NJ) and allowed them to air dry.
The slides were placed in slide boxes, heat-sealed in double bags second agar overlay containing neutral red and observed for several days to obtain optimal plaque counts; titers were expressed as in the BSL-4 laboratory, passed through a 3% lysol immersion tank, and frozen on dry ice before being irradiated with 2 1 10 6 rads of plaque-forming units per milliliter. Again, If the plaque assay yielded no detectable virus plaques and the isolation attempt on gamma in a cobalt irradiator. Following fixation with acetone, the cells were stained with a 1:100 dilution of the polyvalent hyperimthe same specimen was positive, we recorded the virus titer for the specimen as 1.0 log 10 pfu/mL. mune rabbit serum (2 wells) that was used in the antigen-detection assay and with normal rabbit serum (2 wells) followed by a fluoresFluorescent focus assay (FFA). The FFA was based on the technique of Smith et al. [14] . Ten-fold dilutions of samples were cein isothiocyanate-conjugated anti-rabbit IgG (ICN, Irvine, CA); they were then observed with a fluorescent microscope for specific prepared in medium (Eagle MEM with Hanks' balanced salt solution, 2% heat-inactivated fetal bovine serum, 100 U/mL penicillin, EBO viral antigens. Slides with inactivated and fixed cells that were infected with EBO-Z virus were used to control each batch of slides 100 mg/mL streptomycin, and 50 mg/mL gentamycin), and 0.1-mL volumes were inoculated into duplicate wells of Vero E6 that was tested for EBO virus antigen. If specimens were virus isolation positive but had no detectable plaques, they were assigned monolayers in Lab-Tek 8-chamber culture slides (Nunc, Naperville, IL). The inocula were adsorbed for 1 h at 37ЊC, and the a value of 1.0 log 10 pfu/mL for analyses.
Virus plaque assay. Plaque assays were performed in a BSLvolume of medium in each well was brought up to 0.4 mL. Fluorescent foci were detected and counted by indirect immunofluores-4 laboratory according to the method of Earley et al. [12] and Moe et al. [13] on confluent monolayers of Vero E6 cells in 6-well cence with hyperimmune rabbit anti-EBO serum in replicate cultures following 3-5 days of incubation. Titers were expressed as plastic tissue culture plates. The initial samples of the prototype virus from the 1995 Kikwit outbreak that were isolated in Vero fluorescent focus-forming units/mL. E6 cells were passaged one more time (Vero E6/2) and used to establish and control the plaque assay. Samples were diluted 10-fold in Hanks' balanced salt solution with 5% heat-inactivated In the patients who survive beyond this point, antigen declines to unmeasurable levels by day 14 or 15 after symptom onset. Attempts to quantitate the virus by plaque assay in Vero E6 cells were disappointing. Although the virus was easily isolated from most patients in the acute stage of the disease, the number of specimens from which virus was isolated that also had virus plaque assay titers that were ú1.6 log 10 /mL (the minimum detectable) was very small (figure 4). Plaque counts were obtained for relatively few samples; however, those samples with recordable virus titers or that were positive by virus isolation present a clear temporal pattern of viremia that is similar in appearance to the antigen-detection test results shown in figure 3 .
We also attempted to quantify virus by using an FFA that enumerates virus by immunofluorescent staining of infected cells. There were 38 serum or blood samples tested by both methods. The FFA was more successful in determining virus titers among the samples tested. The correlation between the standard plaque assay and the FFA is shown in figure 5 . Al- we were able to isolate virus from all samples that had measursingle data points.
able virus by the FFA. Although our attempts to quantify viremias by plaque assay appear to be less successful than we had anticipated, controls that were included with each assay yielded consistent titers with a virus that had been isolated from the all tests. A subset of 465 specimens from 50 patients was selected for simultaneous testing for virus antigen and antibody; first group of Kikwit patients and that had been passaged only twice to obtain sufficient working stocks. Virus isolation was however, the last set of IgG tests on 20 EHF patients was not performed simultaneously with this batch. also attempted in flasks from each specimen chosen for virus assay, and the results were frequently positive when the plaque Antigen-detection tests were the primary means of identifying acute cases of EHF during the Kikwit epidemic. The data assay did not yield recordable counts. Nevertheless, figure 4 plainly shows that virus isolation attempts from serum samples shown in figure 1 represent the EBO virus antigen, IgM, and IgG test results for the first samples obtained from EHF pawere only rarely positive after day 12.
The evolution of IgM antibody in EHF patients is presented tients; however, they were restricted to those obtained between days 5 before and 10 days after the recorded onset of disease.
in figure 6 . The IgM values appeared to peak among patients Ç18 days after onset; this time point included very few patients Most of the patients' initial specimens were antigen positive, with high titers and high sum OD values, but a few samples who did not eventually survive their infections. IgM antibody, as shown in figure 2 , was found in fewer than half of the had no detectable antigen. Figure 2 presents the antigen-detection and IgM and IgG antibody findings for 7 EHF patients patients (3/7) at the time of their deaths. Mean IgG antibody titers (figure 7) appear to reach maximum levels slightly later from whom samples were obtained on the day of death.
Although limited in number, these data clearly show the than the mean for EBO IgM. The EBO IgM antibodies in survivors are relatively short lived and seem to decline more advantages of the antigen-detection assay over the tests used to measure antibody in samples obtained when EHF patients rapidly than other IgM class viral antibodies measured by the IgM-capture ELISA. die. While the IgM ELISA, and to a lesser extent the IgG ELISA, was positive in many of the samples, the OD sums
We also attempted to follow a group of survivors, for about 2 years, to obtain more information about the persistence of and titers for the two tests were generally in the lower portions of the range of these tests, while the antigen-detection values antibody. While the numbers of patients are small, individuals still had detectable IgG antibody titers when samples were were at the higher end of the range for this test. Figure 3 presents the composite mean EBO virus antigen findings for collected nearly 2 years after onset of illness (figure 7). While these results are encouraging, the specific signal, particularly EHF patients after the recorded day of disease onset. While the data consist of relatively small numbers of individual speciwhen considering the adjusted OD (measured at 410 nm) sums, would be better if it provided more specific signal. Some of mens at any time point, a clear pattern can be seen in the increasing quantities of EBO virus antigen from onset of clinithe individual patient values diminish toward the numeric cutoff value, which was necessitated by the relatively high adcal symptoms through day 10, which is the approximate mean time of death for EHF patients who succumb to their infections.
justed OD sums seen in the general population (higher ratios / 9d49$$se45 01-05-99 13:18:02 jinfa UC: J Infect of signal to noise). Again, detectable IgM antibody was much come among the patients for whom multiple samples were available. These data show only moderate differences between more ephemeral, largely disappearing after Ç60 days after the recorded onset of disease (figure 6).
those who survived and those who succumbed to the disease (figure 8). The lack of discrimination may be partially due to The mortality outcome of other viral hemorrhagic fevers has been associated with the amplitude of viremias during the early antigenemias having reached maximum scale, particularly when using the titer values. However, the viremia data, while course of the disease [15] . We attempted to examine if there was a correlation between viral antigenemia and disease outsubject to some complication because of the performance of was delayed until the epidemic had been virtually controlled the plaque assay, seem to suggest that there were higher mean and EBO virus transmission in the community had largely virus titers in patients who died than in those who survived ceased. The control of the epidemic was a major accomplish-(figure 9).
ment, but because efforts were diverted to that task rather than to sample collection, the number of patients from whom serial samples were obtained to establish the natural evolution of the Discussion detectable antigen and IgG and IgM antibodies was small. Despite the large number of EHF cases during the Kikwit Nevertheless, these data do validate the use of the antigendetection test as a means of detecting acute infections with epidemic of 1995, the systematic collection of patient material EBO virus. The data suggest that while antibody is present in control, an isolate of virus from an early EHF patient in the Kikwit epidemic, yielded consistent plaque titers throughout many of the patients during the acute phase of the disease, the antigen OD values and titers are high and the IgM and IgG the testing period. Perhaps there were inhibitors in many of the patient samples that limited the size of viral foci to less values are low, thus making interpretation of the antigen test much more certain. Indeed, the antigen-detection ELISA has than visible size. When comparing patients who died and those who survived, been used to detect EBO virus infections in patients in Côte d'Ivoire [16], South Africa [3] , and Kikwit [5] and among we noted apparent differences between the mean values for EBO antigen detected and virus titer. This finding is similar to primates in the United States in 1989, 1990 [9] , and 1996 [17] .
While the RT-PCR assay probably has greater absolute senthat described for Lassa fever [15] , in which early higher viremias were associated with poor prognosis. The utility of transsitivity in terms of the quantity of the virus that the test can detect, the antigen-detection ELISA has provided results that fusions of convalescent blood is the topic of an accompanying paper [19] , and a similar comparison among those who received have agreed in virtually 100% of the specimens obtained from acutely ill EHF patients tested in parallel [6] . Despite this transfusions of whole convalescent blood and those who did not showed no apparent differences in either virus antigen or concordance, the antigen-detection ELISA did not detect EBO virus antigens in semen samples from convalescent patients virus titers (data not shown). The RT-PCR and the EBO antigen -detection ELISA both who were positive by RT-PCR [18] ; however, the same samples also failed to yield infectious virus in our isolation attempts, offer the advantage of testing samples that have been rendered noninfectious by the use of chaotrope or gamma irradiation, including repeated efforts with extended culture.
Our ability to quantitate virus in EHF patient serum or blood respectively, and thus allow safe handling of materials outside of the confines of a BSL-4 laboratory. Because blood samples was limited in attempts using a standard plaque assay [12, 13] employing neutral red staining; the FFA was better able to may not be obtained from patients who have already expired and because, in some remote areas, there may not be readily quantitate virus, perhaps because the assay depends upon microscopic identification of infected cells. This may allow visuavailable means for refrigerating and transporting frozen materials, the use of immunohistochemical antigen detection in fixed alization of small viral foci that were not visible as plaques in the neutral red plaque assay. This is intriguing because the tissues should also be considered [20] .
